Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Karasik, Avraham, Lanzinger, Stefanie, Chia-Hui Tan, Elise, Yabe, Daisuke, Kim, Dae Jung, Sheu, Wayne H-H, Melzer-Cohen, Cheli, Holl, Reinhard W., Ha, Kyoung Hwa, Khunti, Kamlesh, Zaccardi, Francesco, Subramanian, Anuradhaa, Nirantharakumar, Krishnarajah, Nyström, Thomas, Niskanen, Leo, Linnemann Jensen, Majken, Hoti, Fabian, Klement, Riho, Déruaz-Luyet, Anouk, Kyaw, Moe H., Koeneman, Lisette, Vistisen, Dorte, Carstensen, Bendix, Halvorsen, Sigrun, Langslet, Gisle, Fazeli Farsani, Soulmaz, Patorno, Elisabetta, Núñez, Júlio
Published in Diabetes & metabolism (01.03.2023)
Published in Diabetes & metabolism (01.03.2023)
Get full text
Journal Article
P5003Reduced healthcare utilization in routine care initiators of empagliflozin with and without heart failure: interim analysis from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Pawar, A, Patorno, E, Deruaz-Luyet, A, Brodovicz, K, Ustyugova, A, Gautam, N, Santiago Ortiz, A, Schneeweiss, S, Najafzadeh, M
Published in European heart journal (01.10.2019)
Published in European heart journal (01.10.2019)
Get full text
Journal Article
Healthcare resource utilisation after empagliflozin initiation in Europe: real-world evidence from the EMPRISE study
Niskanen, L, Kyaw, MH, Deruaz-Luyet, A, Ustyugova, A, Karlsdotter, K, Tuovinen, M, Casajust, P, Grip, ET, Soreskog, E, Nystrom, T
Published in DIABETOLOGIA (2021)
Get full text
Published in DIABETOLOGIA (2021)
Conference Proceeding
Empagliflozin selected cardiovascular and safety outcomes in routine care: First results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Patorno, E., Pawar, A., Franklin, J.M., Najafzadeh, M., Déruaz-Luyet, A., Brodovicz, K.G., Sambevski, S., Bessette, L.G., Kulldorff, M., Schneeweiss, S.
Published in Metabolism, clinical and experimental (01.03.2020)
Published in Metabolism, clinical and experimental (01.03.2020)
Get full text
Journal Article
PDB126 COMPARATIVE HEALTHCARE COSTS AND MEDICATION BURDEN IN REAL-WORLD PATIENTS AUGMENTING METFORMIN MONOTHERAPY WITH EMPAGLIFLOZIN FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY
Pawar, A., Patorno, E., Déruaz-Luyet, A., Brodovicz, K.G., Ustyugova, A., Bessette, L.G., Santiago Ortiz, A.J., Schneeweiss, S., Najafzadeh, M.
Published in Value in health (01.05.2019)
Published in Value in health (01.05.2019)
Get full text
Journal Article
PDB128 REDUCED HEALTHCARE UTILIZATION IN PATIENTS USING EMPAGLIFLOZIN: AN INTERIM ANALYSIS FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY
Najafzadeh, M., Pawar, A., Déruaz-Luyet, A., Brodovicz, K.G., Ustyugova, A., Bessette, L.G., Gautam, N., Schneeweiss, S., Patorno, E.
Published in Value in health (01.05.2019)
Published in Value in health (01.05.2019)
Get full text
Journal Article
EMPRISE: efficacité cardiovasculaire de l’empagliflozine chez des patients avec et sans maladie cardiovasculaire
Patorno, E., Tesfaye, H., Wexler, D.J., Glynn, R.J., Najafzadeh, M., Bessette, L.G., Zabotka, L.E., Koeneman, L., Déruaz-Luyet, A., Schneeweiss, S., Zimner, S.
Published in Annales d'endocrinologie (01.10.2021)
Published in Annales d'endocrinologie (01.10.2021)
Get full text
Journal Article